New York City, New York – (StockNewsDesk) – 10/14/2014 — In this era, modern drugs have produced dramatic results, although troubles about the side effects remain a concern. Think about a world where you do not have to take a pill every day, and imagine the medicine grows inside your body. To bring this technology to life is a challenge to the modern-day technology. Max Myakishev, resident of Rochester, NY, is working on this technology to produce laser-based gene therapies where you can even control when you need to produce the medicine inside your body.
This technology is known as Optogenetics. If you have joint pain, and you visit a doctor, you would probably be treated with a shot of light-inducible therapeutic gene with an LED wrap. The LED wrap is a special treatment that takes about five minutes twice a day. You would not be able to feel the light, but it will manufacture a therapeutic protein and gene. The protein reduces pain and inflammation without the harmful effects of drugs.
The power of controlling gene transfection in the body is a centralized problem in treating gene therapy. The technology that allows light-induced delivery of drugs, DNA and other factors within the cell is called photochemical internalization. It needs a photosensitizer that is added to the drug-delivery system to destabilize the endosomal membrane. The advanced regulatory gene systems are needed for gene-based medicine, synthetic biology, and scientific research.
Several thousand patients who received gene therapy in many clinical trials have been cured. There are several therapy treatments that are approved for commercial use in Asia and Europe. The traditional gene therapy does not implement light, so there is less control when and where it works. So the effects are systemic and there has been no way to control what occurs once the drug is inside the body. The gene therapy is slowly progressing, and it gives a better impact for a perfect therapy.
The use of DNA as a drug to treat disease is a gene therapy that gives the therapeutic DNA into the cells of a patient. The most common form of the therapy involves using DNA that passes a therapeutic and functional gene to change a mutated gene. The DNA is expressed by cell machinery that results in the manufacture of the therapeutic protein, which treats the disease of the patients.
This research is being conducted by Max Myakishev-Rempel, who focuses on light and DNA and started a fund raising campaign on rockethub to get support for this project. It remains to be seen if he succeeds, but that will a huge step forward for the well beings of human beings.